Clinical Trials Directory

Trials / Completed

CompletedNCT03271840

Registry for Primary Ciliary Dyskinesia

Registry for Primary Ciliary Dyskinesia: : Systematic Data Collection on Incidence, Clinical Presentation, Treatment and Course of the Disease

Status
Completed
Phase
Study type
Observational
Enrollment
12 (actual)
Sponsor
University of Alberta · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Primary Ciliary Dyskinesia (PCD) is a rare disease, which means that any single PCD center has experience with a limited number of patients. PCD Registry is the collection of data about PCD from many centers and countries who treat children with PCD. Collecting data about PCD increase the knowledge on PCD, better describe the course of the disease, and help to better understand the progression of the disease and be used to develop new treatments. In the PCD registry of Alberta, important information about PCD such as time of diagnosis, symptoms, and tests which led to the diagnosis, state of health at diagnosis, the progression of lung function, the occurrence of severe infections, tests and treatments data will be collected from the patients' medical records.

Detailed description

In order to better characterize the clinical course, and improve the diagnosis and treatment of PCD, the investigators propose to establish a provincial PCD registry in Alberta. This registry will be securely linked to the currently existing International Registry for PCD and will allow more researchers to use the information to do research on PCD. The investigators will collect demographic data: current age, sex, age, diagnostic findings and symptoms at diagnosis; in addition, clinical data about PCD which are recorded during the past and future clinical visits and encounters (e.g. lung function, weight, height, infections, treatments, and complications) will also be collected.

Conditions

Timeline

Start date
2017-08-26
Primary completion
2021-11-25
Completion
2021-11-25
First posted
2017-09-05
Last updated
2023-06-06

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03271840. Inclusion in this directory is not an endorsement.